Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K213875Substantially Equivalent

DRI TM Tricyclics Serum Tox Assay

Microgenics Corporation, Fremont CA / Traditional, Substantially Equivalent

K213875 is the FDA 510(k) clearance record for DRI TM Tricyclics Serum Tox Assay, a class II device, cleared for Microgenics Corporation on under FDA product code LFH (U.V. Spectrometry, Tricyclic Antidepressant Drugs). FDA records list 128 510(k) clearances for Microgenics Corporation, from to . As of , FDA records show no recalls naming K213875.

Clearance record

Decision date
Received
(373 days to decision)
Product code
LFH U.V. Spectrometry, Tricyclic Antidepressant Drugs
Regulation
21 CFR 862.3910
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Microgenics Corporation 46500 Kato Rd., Fremont CA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code LFH

Trailing 12 months

FDA records hold no clearances under product code LFH in the trailing twelve months.

FDA records show no clearances under product code LFH in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LFH, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260